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Abstract
Background: Cirrhosis produces variety of symptoms which eventually lead to a negative impact on Health Related
Quality of Life (HRQOL). The general aim of this study was to evaluate the magnitude of poor HRQOL and to assess
factors related with HRQOL in patients with CLD in Pakistan.
Findings: This was a cross sectional study conducted in gastroenterology outpatient clinics of Aga Khan University
Hospital, Karachi on adult patients with cirrhosis. In this study chronic liver disease questionnaire (CLDQ) was used
to assess HRQOL of these patients and CLDQ score was used as an outcome measure to determine factors related
with HRQOL.
273 participants were recruited in the study; 155 (57%) were males. Mean age of participants was 49 ± 11 years. The
most common cause for cirrhosis was viral infection 247(91.5%). Mean Model for End Stage Liver Disease (MELD)
score was 12.6 ± 6.8 and 2/3 of patients 209 (76.6%) had advanced cirrhosis in Child Turcot Pugh (CTP) B or C stage.
Poor HRQOL was seen in 187(69%; 95% C.I.: 63%, 74%) of the participants. Mean CLDQ score was 4.36 ±1.1.
Amongst all of the domains, fatigue domain had lower CLDQ score. Hemoglobin (β= 0.09 [SE = 0.04]), Albumin
(β= 0.32[SE = 0.09]), Diastolic Blood Pressure (DBP) (β= 0.01[0.005) prior history of decompensation (β= 0.98
[SE = 0.39] were significant factors associated with HRQOL in patients with liver cirrhosis.
Conclusion: Frequency of poor health related quality of life determined by CLDQ score is high in patients with
liver cirrhosis. Hemoglobin, serum albumen, prior history of decompensation (like encephalopathy and upper gastro
intestinal bleed), are associated with health related quality of life.
Keywords: Hepatitis, Chronic liver disease, Hepatic encephalopathy, Ascites, Quality of life, Upper GI bleed, Cirrhosis,
Health related Quality of life, Hepatitis C and Hepatitis B
Findings
Background
Recently Quality of Life (QOL) has become the principal
goal of medical care because of the increasing emphasis
on the patients as focal point of health care, patients’
functioning preservation and wellbeing. Henceforth
measurement of patient’s HRQOL is receiving attention
in medical research [1].
HRQOL is a subjective multidimensional concept
which includes functional status, emotional and social
wellbeing as well as general health [2]. Similarly World
Health Organization (WHO) has also expanded and
redefined the definition of health which now includes
mental and social wellbeing, therefore WHO has defined
health as ‘state of complete physical, mental and social
well-being and not merely the absence of disease or in-
firmity’ [3,4]. This relatively new concept of HRQOL as
part of psychosocial outcome has been integrated as a
common approach along with traditional biomedical
outcome in the last two decades of the previous century
and since then it has become an important outcome
measure in the assessment of disease management [5].
There has been a rapid development in the concept of
HRQOL due to growing awareness of the importance of
understanding the effect of health related intervention
on patients’ routine life, rather than only on treatment
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of their bodies. Because this concept is important for
those who live with less optimism of cure such as de-
compensated liver cirrhosis patients therefore HRQOL
is important in terms of physical, and psychosocial well-
being for patients; suffering from chronic debilitating
illnesses [6].
The measurement of HRQOL is especially essential in
patients with cirrhosis where recovery is not always
achievable and HRQOL is reduced. In Pakistan this is
the first attempt (to the best of the investigators’ know-
ledge) to assess HRQOL and elucidate factors associated
with it in CLD patients.
The general aim of this study was to assess HRQOL
in patients with liver cirrhosis. We also aimed to assess
factors (such as age, gender, education, job, etiology of
CLD, history of decompensation of cirrhosis like ascites
or PSE or GI bleed; CTP score/Class, MELD score and
socioeconomic status) related with HRQOL in liver cir-
rhosis patients. The Chronic Liver Disease Question-
naire (CLDQ) is a specific HRQOL tool that has been
developed by Younossi et al. in 1999 on 133 patients
[7]. CLDQ is a validated chronic liver disease specific
instrument and can be used for all types of liver dis-
eases to get significant information about CLD related
HRQOL [8].
Materials and methods
This was a cross sectional study conducted at gastro-
intestinal (GI) outpatient clinic of Aga Khan University
Hospital Karachi from May 2009 to March 2010. Aga
Khan University Hospital is a private, tertiary care hos-
pital in Karachi Pakistan. This University Hospital has
563 beds in operation and provides services to over
50,000 hospitalized patients and to over 600,000 outpati-
ents annually with the help of professional staff and fa-
cilities that are among the best in the region. Ethical
permission was obtained from the Aga Khan university
ethics review committee.
All patients who had established diagnosis of liver cir-
rhosis of any etiology and fulfilling inclusion criteria
were recruited in study after obtaining the informed
consent. The inclusion criteria include all adults age
≥14 years, either history of viral CLD (HBsAg or HCV)
or non viral CLD, history of any of clinical features of
cirrhosis like ascites, encephalopathy or upper GI bleed,
any of the laboratory features including prolonged pro-
thrombin time, decreased albumen and total bilirubin
and any of ultrasonographic evidence of CLD including
shrunken liver, dilated portal vein, splenomegaly. We
used nonrandom purposive technique for recruiting par-
ticipants in the study. We did not include individuals
with concomitant comorbids like heart failure, chronic
renal failure (CRF), chronic obstructive pulmonary dis-
ease (COPD), any malignancy like cancer of the lungs
etc., and inflammatory bowel disease (Ulcerative colitis
and Crohn’s disease). Once the patients consented, their
interviews were conducted in the gastroenterology clinic
room. The baseline information of demographics, educa-
tion, socioeconomic status, marital status, etiology of
CLD, severity of CLD in terms of child score was
recorded from the medical record file of study subjects at
the time of interview in clinic visit. The routine clinical
examination, laboratory parameters such as complete
blood count, prothrombin time (PT) with international
normalized ratio (INR), liver function tests (LFT), Albu-
men, serum creatinine (Cr), blood urea nitrogen, electro-
lytes (Na, K, Cl, Hco3) and ultrasound features of
cirrhosis were recorded from participants’ hospital file on
the predesigned proforma. HRQOL was assessed by using
CLDQ questionnaire and all the questions in CLDQ were
verbally asked in native language if they could not under-
stand English.
CLDQ questionnaire
This is a disease specific type of HRQOL which consists of
29 questions and are assessed on a seven point Likert scale
and responses range from ‘All of the time to none of the
time’. Higher score on the questionnaire is indicative of
minimum symptoms and lower score indicates poorer
symptoms. This instrument incorporates the emotional,
social, physical and mental health and is divided into 6
domains; Abdomen symptoms (AS), Fatigue (FA), Systemic
symptoms (SS), Activity (AC), Emotional function (EF) and
Worry (WO). Each domain has different number of ques-
tions like abdomen and activity domain has 3 questions
each, fatigue, worry and systemic domain has 5 questions,
and worry domain has 6 questions. These questions are
randomly distributed. We followed the scoring system
devised by Younossi et al. (2001).
Data was analyzed on SPSS-16 version. We made cat-
egories of CLDQ score for determination of frequency of
HRQOL and these categories were good if mean CLDQ
score ≥5 and bad if CLDQ score is <5 [7]. Categories were
made for CLDQ score by assigning the values for each cat-
egory based on the international available literature that
had shown mean CLDQ score of >5 in normal participants
[3,7]. We also used CLDQ score as continuous variable for
regression analysis. Categories were made for age, occupa-
tion, education, socioeconomic class [9,10].
Frequencies and percentages (e.g. Child class or etiology
of CLD) were used for categorical variables, and mean and
standard deviation for continuous variables (e.g. CLDQ
score, MELD score). Student t test was used to assess differ-
ence in mean CLDQ score between males and females,
while one way analysis of variance (ANOVA) was used to
compare mean difference of CLDQ score for different cat-
egories; education classes, occupation, prior history of de-
compensation (like Upper Gastrointestinal bleed, Hepatic
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Encephalopathy and Ascites) of cirrhosis/CLD, income
classes, etiology of CLD and Child Classes (p value <0.05
was taken as significant). Simple linear regression was also
used to determine the relation between CLDQ score and
the independent variables.
Variables found to be significant in simple linear regres-
sion with a p value of <0.25 were included in multiple lin-
ear regression analysis. These variables were prioritized
based on their F change and R2 change. Final model was
selected based on high F change with significant P value
Results
Total of 273 participants were recruited in the study;
among them 155 (57%) were males; mean age of partici-
pants was 49 years (SD±11 years); among them majority of
study participants i-e 184 (67.5%) belonged to age group of
40–60 years. Other demographic attributes are shown in
Table 1. In this study most common cause for cirrhosis was
viral infection 247 (91.5%). Mean CTP score was 8±1.85
and mean MELD score was 12.6± 6.8. Two thirds of parti-
cipants 209 (76.6%) had advanced cirrhosis (CTP B or C).
Poor HRQOL was seen in 187 (69%) of the participants.
Mean score of the CLDQ was 4.36 (SD± 1.1). Amongst all
of the domains, fatigue domain had significantly lower
CLDQ score. Hb (β=0.09 [SE= 0.04]), Albumin (β= 0.32
[SE= 0.09]), diastolic blood pressure (DBP) (β=0.01
[0.005), and prior history of decompensation (β=0.98
[SE= 0.39] were found to be significant factors associated
with liver cirrhosis. Education was also forced into the
final model as it showed significant confounding (change
in β=32%).
Clinical parameters
Two hundred forty seven (90.5%) had viral related cirrhosis.
Overall HCV related cirrhosis is the most common cause
of cirrhosis in 198 (72.5%) participants while HBV related
cirrhosis was only in 49 [Isolated HBV related in 39 (14.3%)
participants and combined HBV/HDV related in 10 (3.7%)
participants] and only 26 (9.5%) had non B non C related
cirrhosis. Mean child score was 8±1.85 with 140 (51.3%)
had child class B, 69 (25.3%) had child class C and
64 (23.4%) had child class C. Mean MELD score was
12.6 (6.8).
Only 93 (34%) participants had history of any decom-
pensation [Ascites 40 (14%), UGI bleed 45 (16.5%) and
hepatic encephalopathy 8(3%)] and majority of partici-
pants about 180 (66%) had no history of cirrhosis related
decompensation.
Study participants’ haemodynamics were essentially nor-
mal with pulse of 77.64±11 b/min, systolic blood pressure
of 112.64±16 mmHg, respiratory rate of 17.05±4.76 br/
min and temperature of 36.99±0.60 0C
Chronic liver disease questionnaire score
Details CLDQ score is given in Table 2, in which it is
clearly seen that among all domains fatigue domain had
significantly lower mean CLDQ score of 4.36 (SD± 1.1).
Majority of the patients (n = 187, 69%; 95% C.I.: 63%,
74%) had poor (<5) CLDQ score.
On multivariable linear regression, Hb (β=0.09 [SE=
0.04]), Albumin (β=0.32 [SE=0.09]), diastolic blood pres-
sure (DBP) (β=0.01[0.005), and prior history of decom-
pensation (β=0.98[SE=0.39] were found to be significant
factors associated with CLDQ score in patients with liver
cirrhosis (Table 3). Interactions were checked for biologic-
ally plausible variables child class, MELD, income class,
education and sodium. No significant interaction was
found. Same variables were then checked for confounding.
Out of these education was found to have significant con-
founding (β change =32%). Hence education was then
forced into the final model.
Table 1 Demographic characteristics of participants with
cirrhosis
Variables Number of participants (%)
Mean age of participants ( ±SD) 49(SD± 11 years)
Age group*
<40 years 55(20.1%)
41-50 years 98(35.9%)
51-60 years 86(31.5%)
>60 years 34(12.5%)
Gender
Male 155(57%)
Female 118(43%)
Occupation^
Labor 66(24%)
Employee 72(26%)
House Wife 105(39%)
Retired 30(11%)
Socioeconomic!
Low income 95(35%)
Middle income 148(54%)
High Income 30(11%)
Education Status
Uneducated 45(17%)
Primary (5 years) 63(23%)
Secondary(10 years) 80(29%)
Higher secondary & above (>10 years) 85(31%)
*Sumskiene J et al., World J Gastroenterol. 2006 Dec 28;12(48):7792–7.
^MitraZandi et al. Health and Quality of Life Outcomes 2005;3:35.
!Federal Bureau of Revenue website and T. Jaffar et al. 2009 Annal of Internal
Medicine.
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Laboratory parameters
Among the Laboratory parameters are these patients
had low mean Hb of 10.65 ± 1.65 gm/dl and low platelets
with median value 87000 (IQR 87; 135). This cohort of
patients also had low protein and with low albumen.
Details are shown in Table 4.
Discussion
This is the first study conducted at a tertiary care hos-
pital in Pakistan, that suggests that majority of the
patients with CLD had poor QOL as assessed by CLDQ
score. This study also found that albumen, diastolic
blood pressure; haemoglobin and prior history of de-
compensation are significantly related with HRQOL in
patients with CLD.
Globally Cirrhosis/Chronic liver disease (CLD) caused
by many entities, is responsible for major mortality and
morbidity [7]. Liver cirrhosis is one of the commonest
conditions for which individuals are hospitalized in
Table 2 CLDQ Score
Variable Minimum Maximum Mean (SD) Algorithm for assigning score
CLDQ domains* Sum of all questions in each domain
Abdomen 3 21 13.47 (5.14)
Fatigue 5 35 19.26 (6.3)
Systemic 5 35 20.98 (6.47)
Activity 3 21 13.14(5.25)
Emotion 8 56 35.76(11.08)
Worry 6 35 23.92(7.68)
Domain Mean CLDQ score Score obtained by dividing total domain
score with number of questions
Abdomen 1 7 4.48(1.71)
Fatigue 1 7 3.85(1.27)
Systemic 1 7 4.19(1.29)
Activity 1 7 4.38(1.75)
Emotion 1 7 4.47 (1.38)
Worry 1 7 4.78 (1.53)
Mean CLDQ 1.3 6.98 4.36 (1.15) Score obtained by dividing number of domains
or Total score/29
Total CLDQ 38.00 202 126.54 (32.97) Sum of all questions
*Domains: (N = indicates the number of questions in CLDQ questionnaire).
Abdominal (AB) = Sum of N1 +N5+N17.
Fatigue (FA) = Sum of N2 +N4+N8+N11+ N13.
Systemic (SY) = Sum of N3 +N6+N21 +N23 +N27.
Activity (AC) = Sum of N7+N9+N14.
Emotion (EM) = Sum of N10 +N12 +N15 +N16 +N19 +N20 +N24 +N26.
Worry (WO) = Sum of N18 +N22 +N25 +N28 +N29.
ABM=AB/3.
FAM= FA/5.
SYM= SY/5.
ACM=AC/3.
EMM=EM/8.
WOM=WO/5.
CLDQM=SUM (OF ABM FAM SYM ACM EMM WOM)/6.
Table 3 Factors determining CLDQ score on multivariable
regression*
Variables β Std. Error 95% CI^
(Constant) 1.465 .550 0.382 ; 2.548
Albumen .302 .099 0.107; 0.497
Diastolic B.P .013 .005 .003; 0.023
Haemoglobin .090 .041 .009; 0.171
Primary Education1 .347 .199 −0.045; 0.739
Secondary Education .244 .201 −0.152; 0.64
Higher Secondary Education
and above
-.121 .209 −0.544; 0.291
Upper GI bleed2 .322 .181 −0.035; 0.678
Hepatic encephalopathy .982 .390 0.214; 1.75
Ascites .158 .192 −0.22; 0.536
*Coefficient of determination (R2) =0.156.
^ CI = Confidence Interval.
1 =Uneducation (reference category).
2 =No history of decompensation (reference category).
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Pakistan where viral related cirrhosis is the most com-
mon cause [11-13]. Therefore it is important to under-
stand the HRQOL in such a debilitating condition
especially in Pakistan where liver transplant facility is
not available. Literature regarding HRQOL is scarce in
the world and especially from Pakistan.
Among the viral causes; HBV associated cirrhosis had
lower CLDQ score as compared to HCV or HBV/HDV
associated cirrhosis. However overall the number of
chronic hepatitis B patients as compared to patients with
hepatitis C was small. This is different from a study [14],
in which they had shown less impairment of quality of
life in patients suffering from HBV associated cirrhosis
as compared to other causes of cirrhosis like HCV or
Cholestatic associated cirrhosis. In an Italian study that
used different questionnaires like SF-36 and Nottingham
Health Profile Questionnaire (NHP) for assessing
HRQOL compare to our study but it also demonstrated
that HRQOL was reduced in patients with liver cirrhosis
[15]. Another study by Foster et al., which has reported
that CLDQ score is more affected in patients with
Chronic Hepatitis C (CHC) associated cirrhosis hence
concluded that the symptoms caused by CHC are quali-
tatively different from those associated with CHB cirrho-
sis [16]. Hence more studies are required to confirm the
poor quality of life in patients with Hepatitis B.
Results in this study have shown that mean CLDQ
score is not significantly different among different age
groups. Hence this suggests that increasing age does not
affect the mean CLDQ score as also shown by Sums-
kiene in their study [3]. Younossi et al. had suggested
that older age affects the QOL in patients with cirrhosis
[5]. However, this result cannot be compared with
Younossi et al. because they had enrolled all types of
CLD patients including patients with hepatocellular car-
cinoma (HCC) whereas this study had enrolled only liver
cirrhosis participants.
Our findings about gender are similar to those
reported by Sumskiene et al. [3]. On comparison of
the mean CLDQ score in different categories of CTP
class lower CLDQ score was seen in child class C as
compared to Child class A. This result is comparable
with the study by Sumskiene et al. (Lithuanian group)
[3]. Sumskiene group had also seen that HRQOL in
cirrhosis worsens with increasing of severity of liver
cirrhosis that is from better HRQOL (Higher CLDQ
score) in CTP A to poor HRQOL (Lower CLDQ
score) in CTP C. Younossi et al. had also suggested
that as disease severity worsens in chronic liver dis-
ease, HRQOL is affected [5]. In this study, results have
shown that neither MELD score nor CTP score was
an independent predictor of CLDQ score. Similarly in
a study conducted in North America which revealed
that HRQOL was not affected by the severity of dis-
ease and these results are comparable with our find-
ings too in terms of severity of life affecting the
quality of life [17]. We also observed that people who
belong to poorer income class had lower CLDQ score.
This finding is similar to a study conducted in Thai-
land in which it was observed that people with low in-
come had poor quality of life [18]. It is plausible that
low income may be associated with low education sta-
tus and delayed detection of CLD because of late help
seeking behavior of less literate participants, it is an
assumption which needs further studies actually. The
low income might have also caused poor nutritional
status that can also affect the QOL.
The mean global CLDQ score is comparable with
scores reported by other international studies for liver
cirrhosis [7,19]. A Thai study had shown that mean
CLDQ score decreases as disease severity worsens from
compensated group (5.2 ± 1) to decompensate group
(4.5 ± 1.2). The Thai study had divided these patients
with chronic hepatitis and CTP A into compensated,
while patients with CTP B and C into decompensated
CLD. The mean CLDQ score which was reported by
Thai group is also comparable with this study’s mean
CLDQ score though slightly lower as compared to de-
compensated CLD. However, mean CLDQ score of com-
pensated CLD was slightly higher in Thai study because
Table 4 Laboratory Parameters for patients with cirrhosis
attending a tertiary care hospital
Variables Mean (SD)
Haematological Parameters
Haemoglobin (gm/dl) 10.65 (1.65)
White cell count(per cmm) 6.08 (3.28)
Platelets * *87.00 (87;135)
Prothrombin Time(Sec) 15.80 (4.79)
Biochemistry
Total Protein (gm/dl) 6.75 (1.32)
Albumen (gm/dl) 2.61 (0.71)
Creatinine (mg/dl) 1.10 (0.57)
Sodium (Meq/L) 134 (5)
Potassium (Meq/L) 3.97 (0.62)
Chloride (Meq/L) 106 (9.6)
Bicarbonate (Meq/L) 20.46 (3.74)
Liver function tests* Median (IQR)
Total Bilirubin (mg/dl) 1.5 (1;2.95)
SGPT (IU/L) 39 (25;58)
SGOT (IU/L) 59 (40;92)
GGT (IU/L) 48 (30;81)
ALK Phosphate (IU/L) 110 (79;166)
*Median and Inter Quartile Range.
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they had also recruited chronic hepatitis patients while
in this study only cirrhotic patients were recruited [18].
However Younossi et al. had reported lower mean
CLDQ score as compared to this study that can be
explained because Younossi had also included patients
with more advanced disease including patients with
hepatocellular carcinoma (HCC) [5]. This variability
among different studies is because of heterogeneous
group of patients being studied in different studies.
Other reason for difference in CLDQ score might be be-
cause of different socioeconomic status and socio-
demographic attributes of study participants.
In this study an independent association of CLDQ
score with various factors of cirrhosis like Alb, Hb, DBP,
prior history of decompensation especially history of
upper GI bleed along with history of HE and education
was seen. Hence this study has identified certain factors
like Hb and Alb which can be corrected and ultimately
will help in better HRQOL and moreover these para-
meters can also be used in the design of randomized
control trials to assess their utility in HRQOL. Different
studies have been conducted to determine factors asso-
ciated with liver cirrhosis but none had shown any con-
sistent factors for HRQOL. A recent study by Les at al
(n = 212) cirrhotic patients in Barcelona Spain had done
study to identify the potential treatable factors associated
with liver cirrhosis. Spanish study had determined that
factors like prior history of decompensation, non-alcohol
etiology (viral and others), hypoalbumenia, decrease in
hemoglobin and female gender are independent predic-
tors of HRQOL [19]. Low hemoglobin (Anemia) may
lead to symptoms like tiredness, shortness of breath,
mild pedal edema, low grade fever, which depend upon
severity of anemia. Low hemoglobin as a determinant of
HRQOL had also been seen in other diseases like
chronic renal failure and congestive heart failure [20,21].
Our study has shown that low Hb had affected the
HRQOL. Low HB in liver cirrhosis is multifactorial;
hypersplenism, poor nutritional intake because of diet
restriction imposed on such patients by community as
well by physicians and history of upper as well as lower
GI bleed in them. With this study we can assume that
HRQOL can be improved with rise in HB either by
transfusion wherever necessary or by giving therapies
such as either erythropoietin or iron supplements like in
other diseases [22]. Low albumen usually indicates poor
nutritional status and associated with low CLDQ score
by impairing the certain domains of CLDQ (Fatigue,
activity, physical functioning and vitality) by usually
causing Ascites [19].
We observed that prior history of decompensation es-
pecially upper GI bleed was associated with CLDQ
score. Any history of decompensation suggestive of fairly
advanced stage of CLD therefore HRQOL among such
patients would be low. Hence it can be emphasized that
timely management of such complications would lead to
higher CLDQ score that ultimately would translate into
better HRQOL and improve the survival as well [23]. An
interesting finding our work is that diastolic blood pres-
sure is also an independent predictor of mean CLDQ
score. Till to date association between diastolic blood
pressure and CLDQ score has not been reported. How-
ever, over the last two decades researchers have been
trying to see the hemodynamic effects and arterial com-
pliance in patients with liver cirrhosis. As this is estab-
lished fact that liver cirrhosis does cause major
hemodynamic changes in body which include abnormal
distribution of blood flow and volume, that lead to car-
diovascular dysfunction, alteration in rennin angiotensin
system and effect on systemic vascular resistance
[24,25]. Studies have assessed overall arterial compliance
in patients with liver cirrhosis but none of these have
highlighted the importance of maintaining normal dia-
stolic blood pressure [24,25]. Another study done on cir-
rhotic patients to determine the 24 hour blood pressure
recording because these patients have abnormal systemic
haemodynamics with reduced arterial blood pressure. In
their study they had determined that Cirrhotic patients
have raised pulse, but interestingly these patients had
normal arterial pressure during night time. They had
also determined that circadian rhythm in blood pressure
and pulse was diminished. Their results may suggest a
major defect in the ability of optimal regulation of blood
pressure in cirrhotic patients [26]. Despite this we are
not sure whether this is just a statistical association or
there is some biological plausibility for diastolic blood
pressure. This issue needs further research.
Limitations
Since this is a cross sectional study, we cannot make
conclusions about causality (eg low Hb causes low
CLDQ score etc.) we can only suggest that these factors
are associated with CLDQ score. Also majority of the
participants had chronic hepatitis C (CHC) so these
results cannot be corroborated to other causes of CLD
hence causing limited external validity. This study has
limited external and internal validity because a very
selective group of patients with well compensated cir-
rhosis and only outpatients from one tertiary care hos-
pital were enrolled but based on our findings a larger
study, involving several hospitals can be conducted
to confirm our findings. Another limitation was that
patients with advanced hepatic encephalopathy were
not enrolled because of their inability to give consent
and answer the questions. In fact hepatic encephalop-
athy is a major determinant of HRQOL in patients with
CLD.
Parkash et al. BMC Research Notes 2012, 5:446 Page 6 of 8
http://www.biomedcentral.com/1756-0500/5/446
Conclusion
We conclude that majority of the patients with CLD had
poor QOL as assessed by CLDQ score. We have also
determined that hemoglobin, serum albumen, prior his-
tory of decompensation like encephalopathy and upper
gastrointestinal bleed are associated with HRQOL of life
as suggested by CLDQ score therefore HRQOL can be
improved if these factors are taken care of on time.
Recommendations
It is recommended that study evaluating HRQOL in
patients with cirrhosis and healthy controls should be
done to determine the true prevalence of QOL impair-
ment associated with liver cirrhosis in a large population
based study. A further improvement on this recommen-
dation would be to develop a longitudinal follow-up
study on such patients.
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